Melissa Bradford-Klug

Melissa Bradford-Klug is an accomplished professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as a Board Member for MassBio, Melissa provides strategic guidance on public policy and economic development matters for the organization's support of the life sciences sector. Previous roles include Chief Operating Officer at Akari Therapeutics, President & Chief Business Officer at RareStone Group, and Chief Executive Officer at Mayfield Pharmaceuticals. Additional significant positions include Chief Business Officer at Keryx Biopharmaceuticals and Sr. Vice President of Business Development & Strategy at AMAG Pharmaceuticals. Melissa's career began at Monsanto Company and has included key roles at Baxter, Mallinckrodt Pharmaceuticals, and Eli Lilly & Company. Melissa holds an MBA in Finance from DePaul University.